RNXT
RNXT
NASDAQ · Biotechnology

Renovorx Inc

$1.12
-0.04 (-3.45%)
As of Nov 14, 2:39 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +3,243.8% upside
Low Target $24.30
Average Target $37.45
High Target $44.03
Current Price $1.12
Current
$1.12
Target
$37.45
$24.30 $37.45 avg $44.03
Scenario Analysis
Bear Case
$24.30
2,069.6%
Low target
Base Case
$37.45
+3,243.8%
Avg target
Bull Case
$44.03
+3,831.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.59
-56.8% from high
52-Week Low
$0.70
+59.9% from low
Target vs 52W High
$37.45
+1,345.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%